Phibro Animal Health Corporation (NASDAQ:PAHC) Receives $31.40 Consensus Price Target from Brokerages

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) have been given a consensus rating of “Hold” by the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $31.40.

PAHC has been the topic of a number of analyst reports. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Monday, December 29th. JPMorgan Chase & Co. boosted their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday, November 7th. Finally, Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 9th.

Insider Transactions at Phibro Animal Health

In other news, CEO Jack Bendheim sold 38,303 shares of the company’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $45.29, for a total value of $1,734,742.87. Following the transaction, the chief executive officer owned 20,577 shares in the company, valued at approximately $931,932.33. This represents a 65.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders have sold 151,115 shares of company stock valued at $6,557,541 over the last three months. 50.13% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC increased its holdings in shares of Phibro Animal Health by 113.2% in the 4th quarter. Farther Finance Advisors LLC now owns 727 shares of the company’s stock worth $27,000 after purchasing an additional 386 shares in the last quarter. Hughes Financial Services LLC purchased a new stake in shares of Phibro Animal Health during the third quarter valued at $40,000. iSAM Funds UK Ltd bought a new stake in Phibro Animal Health in the 3rd quarter worth about $61,000. Advisory Services Network LLC purchased a new position in Phibro Animal Health in the 3rd quarter worth about $96,000. Finally, EverSource Wealth Advisors LLC lifted its stake in Phibro Animal Health by 7,671.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock valued at $69,000 after acquiring an additional 2,685 shares during the period. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $39.89 on Tuesday. The company’s fifty day moving average price is $39.90 and its 200-day moving average price is $37.71. The stock has a market cap of $1.62 billion, a PE ratio of 24.03, a price-to-earnings-growth ratio of 1.10 and a beta of 0.79. The company has a current ratio of 3.09, a quick ratio of 1.35 and a debt-to-equity ratio of 2.32. Phibro Animal Health has a 12 month low of $16.16 and a 12 month high of $46.42.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.15. The company had revenue of $363.89 million during the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health had a net margin of 4.85% and a return on equity of 36.26%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, equities analysts expect that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 28.92%.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.